Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yichen Zhong

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Pharmacoeconomics|October 14, 2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's PerspectiveTingting Qu, Shujing Zhang, Yichen Zhong, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2014
Nonlinear trajectory of GFR in children before RRTYichen Zhong, Alvaro Muñoz, George J Schwartz, et al.
Journal of Biomedical Science|August 13, 2025
Development of mRNA-lipid nanoparticle intrabodies against rickettsial infectionQi Yan, Nan Duan, Mingqun Lin, et al.
Journal of Psoriasis and Psoriatic Arthritis|November 25, 2024
Criteria for Identifying Candidates for Systemic Psoriasis Treatment in the Real World: Application of the International Psoriasis Council Guidelines in Patients in North AmericaBruce Strober, Yichen Zhong, Adam Sima, et al.
The Journal of Dermatological Treatment|July 30, 2024
Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in AustraliaSaxon D Smith, Simon Fifer, Meredith Edwards, et al.
Current Medical Research and Opinion|January 20, 2015
The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomasAlexander R Macalalad, Megan McAuliffe, Hongbo Yang, et al.
The Journal of Dermatology|August 10, 2022
Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database studyYayoi Tada, Hyunchung Kim, Dionysis Spanopoulos, et al.
Journal of the American Academy of Dermatology|March 25, 2023
Variables associated with joint involvement and development of a prediction rule for arthritis in patients with psoriasis. An analysis of the Italian PsoReal databaseKristine Heidemeyer, Simone Cazzaniga, Letizia Dondi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2022
Prevalence of psoriatic arthritis among patients with psoriasis in ItalySimone Cazzaniga, Kristine Heidemeyer, Letizia Dondi, et al.
Nature Communications|September 25, 2025
Large lithium-ion battery model for secure shared electric bike battery in smart citiesDonghui Ding, Zhao Li, Linhao Luo, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics|October 14, 2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's PerspectiveTingting Qu, Shujing Zhang, Yichen Zhong, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2014
Nonlinear trajectory of GFR in children before RRTYichen Zhong, Alvaro Muñoz, George J Schwartz, et al.
Journal of Biomedical Science|August 13, 2025
Development of mRNA-lipid nanoparticle intrabodies against rickettsial infectionQi Yan, Nan Duan, Mingqun Lin, et al.
Journal of Psoriasis and Psoriatic Arthritis|November 25, 2024
Criteria for Identifying Candidates for Systemic Psoriasis Treatment in the Real World: Application of the International Psoriasis Council Guidelines in Patients in North AmericaBruce Strober, Yichen Zhong, Adam Sima, et al.
The Journal of Dermatological Treatment|July 30, 2024
Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in AustraliaSaxon D Smith, Simon Fifer, Meredith Edwards, et al.
Current Medical Research and Opinion|January 20, 2015
The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomasAlexander R Macalalad, Megan McAuliffe, Hongbo Yang, et al.
The Journal of Dermatology|August 10, 2022
Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database studyYayoi Tada, Hyunchung Kim, Dionysis Spanopoulos, et al.
Journal of the American Academy of Dermatology|March 25, 2023
Variables associated with joint involvement and development of a prediction rule for arthritis in patients with psoriasis. An analysis of the Italian PsoReal databaseKristine Heidemeyer, Simone Cazzaniga, Letizia Dondi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2022
Prevalence of psoriatic arthritis among patients with psoriasis in ItalySimone Cazzaniga, Kristine Heidemeyer, Letizia Dondi, et al.
Nature Communications|September 25, 2025
Large lithium-ion battery model for secure shared electric bike battery in smart citiesDonghui Ding, Zhao Li, Linhao Luo, et al.
Pageof 9